Taking a week off Mounjaro: what your body actually experiences

What happens in your body when you skip a week's injection?

Mounjaro works because tirzepatide mimics two gut hormones (GIP and GLP-1) that signal fullness and slow the rate at which the stomach empties. Once you inject, those signals persist well beyond the day of the dose. The medicine's half-life sits at around five days, which means roughly half of it is still circulating a week later. A single missed dose is unlikely to cause an abrupt reversal of the appetite changes you have been experiencing.

What you may notice is a gradual softening of those effects. Hunger can edge back up, food may feel less filling than it did at the peak of the dosing cycle, and the slight queasiness that some people felt after early injections may fade — which sounds welcome, but can also mean the medicine's grip on appetite is loosening. The speed of this varies considerably between individuals, depending on the dose reached, how long you have been on treatment and your own metabolism.

The how tirzepatide works page goes into more detail on the pharmacology if you want the fuller picture. The practical point here is that a one-week break is unlikely to undo months of progress, but it is not consequence-free either.

Does taking a break mean you have to restart from the beginning?

Not necessarily, but it depends on how long the break is and why it happened. The Mounjaro prescribing guidance, reflected in the NHS tirzepatide medicines page, advises that if you miss a dose by more than four days, you should skip that dose and take the next one on your original scheduled day. A gap of less than four days simply means taking the missed dose as soon as you remember, then returning to your usual weekly schedule.

A deliberate week off (planned travel, a surgical procedure, or a short illness) sits in more nuanced territory. Clinicians often recommend stepping back by one dose level when restarting after a break of more than a week or two, precisely because the GI side effects that settled during your titration phase can return when the medicine's levels have dropped and then rise again quickly. That is a clinical judgement, not a rule anyone should apply to themselves without advice.

If you are thinking about whether a week off Mounjaro is safe in your specific situation, the answer is best given by the person who knows your health history. Pausing and resuming without guidance risks either unnecessary discomfort or, if you push ahead at a higher dose, more pronounced side effects on restart.

Are there situations where a break is genuinely advised?

Yes. Surgery is the clearest example. NHS England recommends telling your anaesthetist and surgical team that you are taking a GLP-1 medicine before any procedure, because slowed gastric emptying can increase the risk of aspiration under general anaesthetic. Your surgical team may ask you to stop Mounjaro a week or more before the procedure, this is a safety measure, not a sign the treatment has failed.

Severe gastrointestinal illness is another case. Persistent vomiting or diarrhoea can lead to dehydration quickly on these medicines, and your prescriber may advise holding the injection until you have recovered. Similarly, pregnancy, trying to conceive, and breastfeeding are situations where treatment should be paused, these medicines are not recommended during any of those periods, and a prescriber should be involved in the planning well in advance.

For people managing their treatment through ongoing Mounjaro care, these scenarios are worth knowing about before they arise. Waiting until you are already mid-illness to ask the question makes the conversation harder. Reporting any concerns through the aftercare support line at any point is always the right call.

What should you actually do if you have already missed a week?

First, check where you are in your dosing cycle. If fewer than four days have passed since the missed injection was due, you can take it and return to your normal weekly rhythm. If more than four days have passed, the standard advice is to skip it entirely and wait for your next scheduled dose day, and our guide to taking Mounjaro covers exactly how to get back on track from there.

Second, tell your prescriber what happened. This is not about needing permission retroactively; it is about making sure your next review reflects your actual dosing history rather than an assumed one. A prescriber assessing whether to step your dose up or down needs accurate information, a missed week changes that picture.

Third, consider whether the break was avoidable and, if not, whether it is likely to happen again. Supply gaps are one of the most common reasons people take an unintentional break; understanding how Mounjaro supply works through a regulated UK pharmacy can help you plan ahead. At nume, every repeat order goes through a same-day clinical review before dispatch (the free consultation page explains the full process) which also means your prescriber sees your dosing history each time.

Finally, do not assume that because one week passed without drama you can take breaks freely. Some patients ask about taking Mounjaro twice a week to make up for lost ground, but this is not something to try without clinical guidance. The medicine works best as a steady weekly rhythm. One gap managed sensibly is very different from treating the schedule as optional.